ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2026
Age-friendly environments and incident motoric cognitive risk syndrome in older adults: A prospective cohort study.
Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
introductionMotoric cognitive risk syndrome (MCR) is a predementia condition that predicts multiple adverse health outcomes. Age-friendly environments (AFE) represent a key strategy for promoting healthy aging and may reduce MCR risk. However, little is known about the association between AFE status and MCR risk.
methodsThis prospective cohort study used data from the National Health and Aging Trends Study. AFE status was assessed across eight domains based on the World Health Organization (WHO) framework. MCR was evaluated annually from 2011 to 2019. Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs); restricted cubic spline regressions were used to examine dose-response relationships.
resultsA total of 7,608 older adults (mean age: 76.81 ± 7.53 years; 57.32% female) without baseline MCR were included. Over a median follow‑up of 4 years, 801 incident MCR cases occurred. Compared with participants in the lowest quartile (Q1) of AFE scores, those in Q3 (HR 0.75, 95% CI: 0.61-0.91) and Q4 (HR 0.62, 95% CI: 0.50-0.78) had significantly lower MCR risks. Additionally, a dose-response association was observed between higher AFE scores and lower risk of incident MCR (HR 0.96, 95% CI: 0.94-0.98). DISCUSSION: AFE was associated with a decreased risk of incident MCR among older adults. These findings suggest that creating AFE may be a feasible population‑based strategy to delay pre‑dementia syndromes, thereby contributing to dementia prevention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.